Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

NCT01383538 is registered in ClinicalTrials.gov with Andrew Ko as lead sponsor.

NCT NCT01383538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01383538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
Lead sponsor
Andrew Ko
Phase
Phase 1
Overall status
Completed
Start date
August 23, 2011
Completion date
May 26, 2015
Enrollment
15 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, pancreatic cancer, pancreatic neoplasms